
A novel inhibitor that targets the AKT node in the PI3K pathway may offer a treatment option for patients with triple-negative breast cancer (TNBC) who are resistant to chemotherapy.

A novel inhibitor that targets the AKT node in the PI3K pathway may offer a treatment option for patients with triple-negative breast cancer (TNBC) who are resistant to chemotherapy.

Yoga is a complementary mind–body therapy that may help people manage cancer symptoms or adverse effects of treatments and improve their quality of life.

Clinical Trial in Progress: Investigators are seeking to determine whether the combination of eflornithine with lomustine can improve survival for patients with recurrent anaplastic astrocytoma, a rare form of brain tumor.

Several breast cancer treatment programs are reporting substantially less clinical lymphedema, particularly among patients at high risk after axillary dissection, radiation, or taxane-based chemotherapy, crediting their use of preclinical detection using bioimpedance spectroscopy (BIS).

Consider the family's feelings and check workplace policies when determining how best to share condolences and cope with your grief.

Mail-in DNA tests may not provide enough information to people looking for answers about their genetic predisposition to cancer.

A nurse navigator uses a simple tool to help a forgetful patient overcome a barrier to care.

What can healthcare facilities do to mitigate infestation?

Cancer prehabilitation can combat potential limitations and preventable adverse effects.